ACE inhibitors have been the most well-researched drugs for preventing or treating LV dysfunction; spironolactone would be a protective drug given the rising importance of minerals corticoid antagonists in HF, particularly HF with maintained ejection fraction, and their capacity to reduce fibrous tissue [14]. The gene discussed is ACE; the disease is hydrops fetalis.